Inlyta Clinical Trials
Here are the 6 most popular medical studies for inlyta
Selenium Supplement
SLM + Axitinib for Kidney Cancer
Recruiting3 awardsPhase 1 & 2
Iowa City, Iowa
This trial is testing a new combination of drugs to treat advanced kidney cancer. The first part of the trial will test different doses of the drugs to find a safe dose, and the second part will see if the combination is effective.
PARP Inhibitor
Talazoparib Combinations for Advanced Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is to find the best dose of talazoparib to give with either palbociclib, axitinib, or crizotinib to patients with solid tumors that have spread. The goal is to see if the combination can help control the tumor growth.
Popular filter options for inlyta trials
Clinical Trials With No Placebo
View 30 medical studies that do not have a placebo group.
Axitinib Oral Tablet [Inlyta] for Renal Cell Carcinoma
Recruiting3 awardsPhase 2
La Jolla, California
This is a single arm phase II study of axitinib in patients with clear cell renal cell carcinoma (RCC) with strong indications for partial nephrectomy (PN) for whom PN is not currently possible due to anatomic considerations and residual renal function concerns. Evaluation of tumor downsizing will be performed including changes of tumor complexity by nephrometry score. A total of 50 participants will be enrolled. It is hypothesized that pretreatment with axitinib will be safe and improve the feasibility of complex nephron sparing surgery in select patients with localized clear cell RCC and imperative indications for partial nephrectomy.
Tyrosine Kinase Inhibitor
Nivolumab + Axitinib for Kidney Cancer
Recruiting1 awardPhase 1 & 2
Baltimore, Maryland
This trial is testing a combination of drugs to treat advanced renal cell carcinoma in both previously treated and untreated patients. The first part of the trial will establish a safe and tolerable dose, and the second part will test the efficacy of the combination at that dose.
View More Inlyta Trials
See another 15 medical studies focused on inlyta.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.